Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?

Cancer

Volumn 116, Issue 3, 2010, Pages 723-733

  Cheung, Michael C ^a   Yang, Relin ^a   Byrne, Margaret M ^a   Solorzano, Carmen C ^a   Nakeeb, Attila ^a   Koniaris, Leonidas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Outcomes; Pancreatic cancer; Racial disparities; Socioeconomic status

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; POVERTY; PRIORITY JOURNAL; SOCIOECONOMICS; SURGICAL MORTALITY; SURGICAL PATIENT; TEACHING HOSPITAL;

ADENOCARCINOMA; ADULT; AGED; COMORBIDITY; FEMALE; FLORIDA; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POVERTY; SOCIAL CLASS;

EID: 76249103882     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24758     Document Type: Article

References (53)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg. 1996;223:273-279.
3. Chang KJ, Parasher G, Christie C, et al. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups. Cancer. 2005;103:349-357.
4. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000;88:2398-2424.
5. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
6. Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract. 1993;37:583-587.
7. Chang SW, Kerlikowske K, Napoles-Springer A, et al. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996;78:1395-1402.
8. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
9. Hegarty V, Burchett BM, Gold DT, Cohen HJ. Racial differences in use of cancer prevention services among older Americans. J Am Geriatr Soc. 2000;48:735-740.
10. Liu WL, Kasl S, Flannery JT, et al. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control. 1995;6: 425-430.
11. McCarthy BD, Yood MU, Boohaker EA, et al. Inadequate follow-up of abnormal mammograms. Am J Prev Med. 1996;12:282-288.
12. Optenberg SA, Thompson IM, Friedrichs P, et al. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274:1599-1605.
13. Suarez L, Pulley L. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women. J Natl Cancer Inst Monogr. 1995;18:41-47.
14. Sung HY, Kearney KA, Miller M, et al. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer. 2000;88:2283-2289.
15. Chu KC, Miller BA, Springfield SA. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc. 2007;99:1092-1100, 1102-1104.
16. Zell JA, Rhee JM, Ziogas A, et al. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16:546-552.
17. Baker DW, Sudano JJ, Albert JM, et al. Lack of health insurance and decline in overall health in late middle age. N Engl J Med. 2001;345:1106-1112.
18. Cheung MC, Hamilton K, Sherman R, et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol. 2009;16:3-13.
19. Brookfield KF, Cheung MC, Gomez C, et al. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer. 2009;115:4196-4209.
20. Molina MA, Cheung MC, Perez EA, et al. African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer. 2009;113:2797-2806.
21. DeNavas-Walt C, Proctor BD, Lee CH. US Census Bureau, Current Population Reports, P60-231. Income, Poverty, and Health Insurance Coverage in the United States: 2005. Washington, DC: U.S. Government Printing Office; 2006.
22. Petrelli NJ. Not just another article on cancer surgery volume and patient outcomes. J Clin Oncol. 2008;26:4530-4531.
23. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
24. Silverman DT, Hoover RN, Brown LM, et al. Why do black Americans have a higher risk of pancreatic cancer than white Americans? Epidemiology. 2003;14:45-54.
25. Steinberg ML, Fremont A, Khan DC, et al. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer. 2006;107:2669-2677.
26. Birkmeyer JD, Sun Y, Goldfaden A, et al. Volume and process of care in high-risk cancer surgery. Cancer. 2006;106:2476-2481.
27. Birkmeyer JD, Warshaw AL, Finlayson SR, et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery. 1999;126:178-183.
28. Gordon TA, Bowman HM, Bass EB, et al. Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. J Am Coll Surg. 1999;189:46-56.
29. Gordon TA, Bowman HM, Tielsch JM, et al. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg. 1998;228:71-78.
30. Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for 1 general high-risk surgical procedure. Ann Surg. 1995;221:43-49.
31. Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786-795.
32. Ho V, Heslin MJ. Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy. Ann Surg. 2003;237:509-514.
33. Kotwall CA, Maxwell JG, Brinker CC, et al. National estimates of mortality rates for radical pancreaticoduodenectomy in 25,000 patients. Ann Surg Oncol. 2002;9:847-854.
34. Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222:638-645.
35. Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998;228:429-438.
36. Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246:173-180.
37. Casson AG, van Lanschot JJ. Improving outcomes after esophagectomy: the impact of operative volume. J Surg Oncol. 2005;92:262-266.
38. Cheung MC, Perez EA, Molina MA, et al. Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg. 2008;12:731-738.
39. Gutierrez JC, Kassira N, Salloum RM, et al. Surgery for rectal cancer performed at teaching hospitals improves survival and preserves continence. J Gastrointest Surg. 2007;11:1441-1448; discussion 1448-1450.
40. Gutierrez JC, Perez EA, Moffat FL, et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg. 2007;245:952-958.
41. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18:2327-2340.
42. Meguid RA, Brooke BS, Chang DC, et al. Are surgical outcomes for lung cancer resections improved at teaching hospitals? Ann Thorac Surg. 2008;85:1015-1024; discussion 1024-1025.
43. Riall TS, Eschbach KA, Townsend CM Jr, et al. Trends and disparities in regionalization of pancreatic resection. J Gastrointest Surg. 2007;11:1242-1251, discussion 1251-1252.
44. Hodgson N, Koniaris LG, Livingstone AS, Franceschi D. Gastric carcinoids: a temporal increase with proton pump introduction. Surg Endosc. 2005;19:1610-1612.
45. Perez EA, Koniaris LG, Snell SE, et al. 7201 Carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg. 2007;31:1022-1030.
46. Perez EA, Livingstone AS, Franceschi D, et al. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg. 2006;202:623-629.
47. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003;348:1170-1175.
48. Krieger N, Chen JT, Waterman PD, et al. Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures - the Public Health Disparities Geocoding Project. Am J Public Health. 2003;93:1655-1671.
49. Muss HB. Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status. J Natl Cancer Inst Monogr. 2001:52-55.
50. Soler-Vila H, Kasl SV, Jones BA. Prognostic significance of psychosocial factors in African-American and white breast cancer patients: a population-based study. Cancer. 2003;98:1299-1308.
51. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
52. Newman LA, Griffith KA, Jatoi I, et al. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24:1342-1349.
53. Robert SA, Strombom I, Trentham-Dietz A, et al. Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology. 2004;15:442-450.